Immuron Cost Of Revenue vs Revenue Per Share Analysis

IMRN Stock

USD 1.91 0.02 1.06%

Immuron financial indicator trend analysis is infinitely more than just investigating Immuron Ltd ADR recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immuron Ltd ADR is a good investment. Please check the relationship between Immuron Cost Of Revenue and its Revenue Per Share accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuron Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Cost Of Revenue vs Revenue Per Share

Cost Of Revenue vs Revenue Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immuron Ltd ADR Cost Of Revenue account and Revenue Per Share. At this time, the significance of the direction appears to have very week relationship.

The correlation between Immuron's Cost Of Revenue and Revenue Per Share is 0.21. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Revenue Per Share in the same time period over historical financial statements of Immuron Ltd ADR, assuming nothing else is changed. The correlation between historical values of Immuron's Cost Of Revenue and Revenue Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Immuron Ltd ADR are associated (or correlated) with its Revenue Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Revenue Per Share has no effect on the direction of Cost Of Revenue i.e., Immuron's Cost Of Revenue and Revenue Per Share go up and down completely randomly.

Correlation Coefficient

0.21

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Immuron Ltd ADR income statement and represents the costs associated with goods and services Immuron provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Revenue Per Share

The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.

Most indicators from Immuron's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immuron Ltd ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuron Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

As of the 29th of November 2024, Selling General Administrative is likely to drop to about 4 M. In addition to that, Sales General And Administrative To Revenue is likely to drop to 0.88

	2021	2022	2023	2024 (projected)
Interest Expense	6.2K	9.7K	7.6K	7.2K
Depreciation And Amortization	26.6K	48.7K	46.0K	43.7K

Interest Expense Depreciation And Amortization

Immuron fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Other Assets	Short Term Debt	Current Deferred Revenue	Non Current Liabilities Total
Common Stock Shares Outstanding		0.72	0.62	0.26	0.72	-0.13	-0.79	-0.85	-0.41	0.79	0.27	0.52	0.72	-0.2	0.07	-0.08	-0.29	-0.24	0.07	0.7	0.79	-0.56	0.25	-0.26	0.87	-0.17
Total Assets	0.72		0.41	0.19	0.99	-0.02	-0.95	-0.62	-0.36	0.95	0.17	0.33	0.98	-0.04	0.08	-0.1	0.06	-0.1	0.13	0.99	0.83	-0.41	0.12	-0.08	0.64	-0.27
Other Current Liab	0.62	0.41		0.77	0.35	-0.15	-0.45	-0.69	0.06	0.49	-0.25	0.14	0.34	0.35	0.1	0.42	0.15	0.0	0.48	0.43	0.45	-0.13	-0.21	0.22	0.73	-0.22
Total Current Liabilities	0.26	0.19	0.77		0.08	-0.29	-0.13	-0.46	0.59	0.19	-0.47	0.04	0.07	0.7	-0.06	0.59	0.51	0.05	0.86	0.23	0.26	0.25	-0.47	0.68	0.26	-0.07
Total Stockholder Equity	0.72	0.99	0.35	0.08		0.02	-0.96	-0.6	-0.45	0.95	0.23	0.34	0.99	-0.11	0.1	-0.16	-0.01	-0.1	0.01	0.98	0.81	-0.46	0.18	-0.17	0.65	-0.31
Property Plant And Equipment Net	-0.13	-0.02	-0.15	-0.29	0.02		0.15	0.52	-0.34	-0.17	0.44	-0.68	-0.02	-0.16	0.91	-0.23	-0.22	-0.1	-0.34	-0.06	-0.4	-0.27	0.39	-0.11	0.07	-0.15
Net Debt	-0.79	-0.95	-0.45	-0.13	-0.96	0.15		0.7	0.4	-1.0	-0.11	-0.41	-0.97	0.21	0.04	0.19	0.08	0.14	-0.02	-0.95	-0.82	0.39	-0.07	0.26	-0.69	0.2
Retained Earnings	-0.85	-0.62	-0.69	-0.46	-0.6	0.52	0.7		0.15	-0.71	-0.01	-0.74	-0.58	-0.09	0.27	-0.23	0.03	0.01	-0.27	-0.63	-0.88	0.39	-0.02	0.09	-0.78	0.21
Accounts Payable	-0.41	-0.36	0.06	0.59	-0.45	-0.34	0.4	0.15		-0.35	-0.52	-0.15	-0.4	0.5	-0.3	0.27	0.41	-0.02	0.74	-0.31	-0.27	0.63	-0.52	0.58	-0.49	0.42
Cash	0.79	0.95	0.49	0.19	0.95	-0.17	-1.0	-0.71	-0.35		0.09	0.41	0.96	-0.17	-0.06	-0.17	-0.05	-0.14	0.07	0.95	0.82	-0.37	0.04	-0.21	0.69	-0.17
Non Current Assets Total	0.27	0.17	-0.25	-0.47	0.23	0.44	-0.11	-0.01	-0.52	0.09		0.26	0.17	-0.32	0.41	-0.6	-0.56	-0.37	-0.48	0.07	0.1	-0.79	0.99	-0.43	0.35	-0.05
Non Currrent Assets Other	0.52	0.33	0.14	0.04	0.34	-0.68	-0.41	-0.74	-0.15	0.41	0.26		0.31	0.03	-0.58	-0.06	-0.16	-0.14	-0.02	0.31	0.69	-0.36	0.29	-0.16	0.39	-0.14
Cash And Short Term Investments	0.72	0.98	0.34	0.07	0.99	-0.02	-0.97	-0.58	-0.4	0.96	0.17	0.31		-0.2	0.07	-0.21	-0.05	-0.14	0.04	0.98	0.8	-0.39	0.12	-0.21	0.61	-0.19
Net Receivables	-0.2	-0.04	0.35	0.7	-0.11	-0.16	0.21	-0.09	0.5	-0.17	-0.32	0.03	-0.2		-0.15	0.62	0.75	0.21	0.62	0.0	0.04	0.27	-0.3	0.91	-0.09	-0.34
Short Term Investments	0.07	0.08	0.1	-0.06	0.1	0.91	0.04	0.27	-0.3	-0.06	0.41	-0.58	0.07	-0.15		-0.08	-0.3	-0.13	-0.14	0.04	-0.22	-0.32	0.37	-0.14	0.28	-0.14
Inventory	-0.08	-0.1	0.42	0.59	-0.16	-0.23	0.19	-0.23	0.27	-0.17	-0.6	-0.06	-0.21	0.62	-0.08		0.63	0.65	0.5	-0.04	0.14	0.23	-0.56	0.52	0.04	-0.35
Other Current Assets	-0.29	0.06	0.15	0.51	-0.01	-0.22	0.08	0.03	0.41	-0.05	-0.56	-0.16	-0.05	0.75	-0.3	0.63		0.61	0.52	0.12	0.02	0.32	-0.58	0.79	-0.27	-0.19
Other Stockholder Equity	-0.24	-0.1	0.0	0.05	-0.1	-0.1	0.14	0.01	-0.02	-0.14	-0.37	-0.14	-0.14	0.21	-0.13	0.65	0.61		0.03	-0.06	-0.02	-0.08	-0.37	0.11	-0.07	-0.14
Total Liab	0.07	0.13	0.48	0.86	0.01	-0.34	-0.02	-0.27	0.74	0.07	-0.48	-0.02	0.04	0.62	-0.14	0.5	0.52	0.03		0.18	0.23	0.34	-0.47	0.68	-0.03	0.27
Total Current Assets	0.7	0.99	0.43	0.23	0.98	-0.06	-0.95	-0.63	-0.31	0.95	0.07	0.31	0.98	0.0	0.04	-0.04	0.12	-0.06	0.18		0.83	-0.33	0.02	-0.04	0.6	-0.27
Common Stock	0.79	0.83	0.45	0.26	0.81	-0.4	-0.82	-0.88	-0.27	0.82	0.1	0.69	0.8	0.04	-0.22	0.14	0.02	-0.02	0.23	0.83		-0.42	0.09	-0.1	0.66	-0.25
Short Long Term Debt Total	-0.56	-0.41	-0.13	0.25	-0.46	-0.27	0.39	0.39	0.63	-0.37	-0.79	-0.36	-0.39	0.27	-0.32	0.23	0.32	-0.08	0.34	-0.33	-0.42		-0.79	0.46	-0.7	0.11
Other Assets	0.25	0.12	-0.21	-0.47	0.18	0.39	-0.07	-0.02	-0.52	0.04	0.99	0.29	0.12	-0.3	0.37	-0.56	-0.58	-0.37	-0.47	0.02	0.09	-0.79		-0.43	0.36	-0.03
Short Term Debt	-0.26	-0.08	0.22	0.68	-0.17	-0.11	0.26	0.09	0.58	-0.21	-0.43	-0.16	-0.21	0.91	-0.14	0.52	0.79	0.11	0.68	-0.04	-0.1	0.46	-0.43		-0.3	-0.18
Current Deferred Revenue	0.87	0.64	0.73	0.26	0.65	0.07	-0.69	-0.78	-0.49	0.69	0.35	0.39	0.61	-0.09	0.28	0.04	-0.27	-0.07	-0.03	0.6	0.66	-0.7	0.36	-0.3		-0.28
Non Current Liabilities Total	-0.17	-0.27	-0.22	-0.07	-0.31	-0.15	0.2	0.21	0.42	-0.17	-0.05	-0.14	-0.19	-0.34	-0.14	-0.35	-0.19	-0.14	0.27	-0.27	-0.25	0.11	-0.03	-0.18	-0.28

Click cells to compare fundamentals

Immuron Account Relationship Matchups

Immuron fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	176.4M	221.1M	227.6M	227.8M	228.2M	239.6M
Total Assets	6.2M	27.1M	24.9M	22.0M	15.5M	9.3M
Other Current Liab	42.2K	994.5K	747.7K	691.3K	2.0M	2.1M
Total Current Liabilities	516.4K	1.1M	1.5M	2.2M	2.7M	2.8M
Total Stockholder Equity	5.6M	25.9M	23.2M	19.6M	12.7M	7.9M
Property Plant And Equipment Net	70.8K	33.7K	226.7K	200.1K	154.3K	146.6K
Net Debt	(3.2M)	(25.0M)	(21.9M)	(17.0M)	(11.5M)	(10.9M)
Retained Earnings	(57.9M)	(65.9M)	(68.4M)	(72.1M)	(79.0M)	(75.0M)
Accounts Payable	157.6K	106.9K	720.9K	790.9K	648.9K	744.3K
Cash	3.3M	25.0M	22.1M	17.2M	11.7M	12.2M
Non Current Assets Total	1.8M	1.3M	1.2M	1.6M	823.6K	940.4K
Non Currrent Assets Other	1.7M	1.3M	956.9K	1.2M	669.3K	702.7K
Cash And Short Term Investments	3.3M	25.0M	22.1M	19.0M	11.7M	6.2M
Net Receivables	327.7K	334.7K	662.9K	417.4K	1.4M	846.1K
Liabilities And Stockholders Equity	6.2M	27.1M	24.9M	22.0M	15.5M	10.4M
Inventory	797.7K	292.5K	326.6K	840.0K	1.6M	802.1K
Other Current Assets	33.2K	413.0K	572.4K	158.2K	96.8K	92.0K
Other Stockholder Equity	5.6M	25.9M	23.2M	3.2M	3.7M	3.5M
Total Liab	558.3K	1.2M	1.7M	2.4M	2.8M	1.4M
Total Current Assets	4.4M	25.8M	23.7M	20.4M	14.7M	8.0M
Common Stock	60.5M	62.4M	88.4M	88.4M	88.5M	46.1M
Short Long Term Debt Total	61.1K	20.5K	209.8K	189.1K	173.5K	310.2K
Other Assets	1.7M	1.3M	956.9K	1.2M	1.1M	838.7K
Short Term Debt	42.2K	20.5K	34.4K	38.8K	40.6K	38.5K
Accumulated Other Comprehensive Income	1.1M	3.5M	3.2M	3.2M	3.2M	1.8M
Non Current Liabilities Total	41.8K	36.2K	175.4K	152.2K	141.5K	129.8K
Net Tangible Assets	5.6M	25.9M	23.2M	19.6M	22.6M	12.8M
Property Plant Equipment	70.8K	33.7K	226.7K	200.1K	230.2K	241.7K
Other Liab	22.9K	36.2K	36.0	1.9K	2.2K	2.1K
Capital Lease Obligations	61.1K	20.5K	209.8K	189.1K	217.5K	228.3K
Property Plant And Equipment Gross	499.2K	505.8K	628.9K	651.0K	748.6K	786.1K
Net Invested Capital	5.6M	25.9M	23.2M	19.6M	22.6M	15.3M
Net Working Capital	3.9M	24.6M	22.2M	18.2M	20.9M	13.7M

Pair Trading with Immuron

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immuron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immuron will appreciate offsetting losses from the drop in the long position's value.

Moving together with Immuron Stock

0.72

ELAN

Elanco Animal Health

Pair Corr

Moving against Immuron Stock

0.84	EWTX	Edgewise Therapeutics	Pair Corr
0.83	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.82	GILD	Gilead Sciences	Pair Corr
0.79	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.67	GANX	Gain Therapeutics	Pair Corr

The ability to find closely correlated positions to Immuron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immuron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immuron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immuron Ltd ADR to buy it.

The correlation of Immuron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immuron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immuron Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Immuron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Immuron Ltd ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immuron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immuron Ltd Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immuron Ltd Adr Stock:

How To Invest In Immuron

Details

Is Immuron Stock a good investment?

Details

What is Immuron's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuron Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuron. If investors know Immuron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immuron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.79)

Revenue Per Share

0.88

Quarterly Revenue Growth

1.086

Return On Assets

(0.17)

Return On Equity

(0.43)

The market value of Immuron Ltd ADR is measured differently than its book value, which is the value of Immuron that is recorded on the company's balance sheet. Investors also form their own opinion of Immuron's value that differs from its market value or its book value, called intrinsic value, which is Immuron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immuron's market value can be influenced by many factors that don't directly affect Immuron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immuron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immuron Cost Of Revenue vs Revenue Per Share Analysis

Cost Of Revenue vs Revenue Per Share

Cost Of Revenue vs Revenue Per Share Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Revenue Per Share

Immuron fundamental ratios Correlations

Immuron Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Immuron fundamental ratios Accounts

Pair Trading with Immuron

Moving together with Immuron Stock

Moving against Immuron Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Other Assets	+ 0.99	Non Current Assets Total
Cash And Short Term Investments	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Total Stockholder Equity

Cash	- 1.0	Net Debt
Cash And Short Term Investments	- 0.97	Net Debt
Net Debt	- 0.96	Total Stockholder Equity
Total Current Assets	- 0.95	Net Debt
Net Debt	- 0.95	Total Assets
Common Stock	- 0.88	Retained Earnings